Home > Journals > Minerva Anestesiologica > Past Issues > Articles online first > Minerva Anestesiologica 2022 Jul 14

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Original Paper   

Minerva Anestesiologica 2022 Jul 14

DOI: 10.23736/S0375-9393.22.16104-3

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

The role of F-18 FDG PET/CT in the prognosis of patients with hypoxic/anoxic brain injury after cardio-circulatory arrest

Elena ROSSATO 1 , Renato AVESANI 1, Silvia BONADIMANN 1, Laura OLIVARI 2, Ronaldo SILVA 3, Paolo ZANATTA 4, Andrea LUPI 5, Matteo SALGARELLO 2

1 Department of Rehabilitation Medicine, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; 2 Department of Nuclear Medicine, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; 3 Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; 4 Anesthesia and Intensive Care Unit A, AOUI Verona, Verona, Italy; 5 Department of Nuclear Medicine, S. Bortolo Hospital, Vicenza, Italy


PDF


BACKGROUND: Advances in resuscitation techniques have resulted in more patients surviving cardio-circulatory arrest (CA) and consequently developing hypoxic/anoxic brain damage. The aim of this study is to evaluate the role of PET/CT (Positron Emission Tomography / Computerised Tomography scan) with F-18 FDG (F-18 fluorodeoxyglucose) during the early rehabilitative hospitalization phase in determining the V/C (Vermis/Cerebellar) ratio as a prognostic index to predict patient outcome, as defined by clinical evaluation scales.
METHODS: This is a single-centre retrospective study of 37 consecutive adult patients admitted to the neurorehabilitation center between January 2011 and June 2019. Functional status was measured by the following clinical scales: FIM (Functional Indipendence Measure), LCFS (Levels of Cognitive Functioning Scale), GOS (Glasgow Outcome Scale) and CRS-R (Coma Recovery Scale-Revised). PET/CT with F-18 FDG as a functional imaging technique was used to calculate the V/C ratio as a ratio between the metabolism of the vermis and of the Cerebellar Hemisphere.
RESULTS: A statistically significant correlation was observed between the V/C ratio and the delta values (difference between discharge and admission value) for each clinical evaluation scale (Delta FIM: p=0.0014; Delta LCFS p=0.0003). A statistically significant difference was observed between the V/C ratio of patients with LCFS ≥ 4 that showed an improved outcome (defined as an improvement of at least 2 points in LCFS), and that of patients with LCFS < 4 that did not improve (p=0.0011). A V/C ratio cut-off of 1.5 corresponded with a positive predictive power of 80% and a negative predictive power of 82%; a value < 1.5 predicted a better outcome.
CONCLUSIONS: Clinical evaluation scales when associated with F- 18 FDG PET/CT measurement of metabolism, provide a more reliable prognosis. This allows for more focused rehabilitation treatment and better management of family members’ expectation.


KEY WORDS: Hypoxic/anoxic brain injury; Positron emission tomography; Rehabilitation; Outcome

top of page